Alpha-Lipoic Acid (Ala) for Cognitive Function

Research suggests that alpha-lipoic acid may have neuroprotective properties, though the human evidence remains limited and inconsistent. The available studies include two randomized controlled trials, several animal studies, and small human observational studies, with animal research generally showing supportive findings across multiple models — including aging mice, Alzheimer's transgenic mice, and surgical injury models — pointing to mechanisms involving reduced neuroinflammation, mitophagy activation, and preservation of synaptic structure. However, one double-blind placebo-controlled trial in schizophrenia patients found no cognitive benefit and raised a safety concern regarding blood cell counts, while a small open-label pilot study in older adults without cognitive impairment found no statistically significant improvements, underscoring how difficult it is to translate promising animal findings into demonstrated human benefit. Studies indicate that certain populations, such as people with type 2 diabetes or those undergoing specific surgical procedures, may represent more targeted areas of investigation, but the overall human evidence base is too preliminary, small in scale, and methodologically varied to draw firm conclusions about alpha-lipoic acid's effects on cognitive function.